Topoisomerase II Poisoning by ICRF-193
Open Access
- 1 November 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (48), 44488-44494
- https://doi.org/10.1074/jbc.m104383200
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Inhibition of topoisomerase II by ICRF-193, the meso isomer of 2,3-bis(2,6-dioxopiperazin-4-yl)butane: Critical dependence on 2,3-butanediyl linker absolute configurationBiochemical Pharmacology, 1996
- Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycleBiochemical Pharmacology, 1996
- A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane)Biochemical Pharmacology, 1995
- Inverse Relationship Between Catenation and Superhelicity in Newly Replicated Simian Virus 40 Daughter ChromosomesBiochemical and Biophysical Research Communications, 1994
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.Molecular and Cellular Biology, 1986
- Stereochemistry of the antitumor agent 4,4'-(1,2-propanediyl)bis(4-piperazine-2,6-dione): crystal and molecular structures of the racemate (ICRF-159) and a soluble enantiomer (ICRF-187)Journal of the American Chemical Society, 1982
- Biological Properties of ICRF-159 and Related Bis(dioxopiperazine) CompoundsPublished by Elsevier ,1982
- Biochemical studies on growth‐inhibitory bisdioxopiperazines. I. Effect on dna, rna and protein synthesis in mouse‐embryo fibroblastsInternational Journal of Cancer, 1970
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969